A multicentre prospective study published in 2026 evaluated transvaginal radiofrequency ablation as a minimally invasive option for treating uterine fibroids.

The procedure uses thermal energy to treat fibroid tissue through a transvaginal approach. The research focuses on systematically assessing efficacy, safety and reproducibility across patients and clinical teams.

An option that requires appropriate selection

The findings do not mean the technique is suitable for every fibroid or patient. Size, location, symptoms and reproductive goals remain important factors in treatment planning.

Source: Journal of Minimally Invasive Gynecology, 2026 multicentre prospective study.